What are the major opportunities in the typhoid Vi polysaccharide vaccine market? What are the strategies for the typhoid Vi polysaccharide vaccine market?

For detailed insights on the major opportunities and strategies in the typhoid Vi polysaccharide vaccine market, Read More

How does the typhoid Vi polysaccharide vaccine market relate to the overall economy and other similar markets?

For detailed insights on typhoid Vi polysaccharide vaccine market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the typhoid Vi polysaccharide vaccine market growth? SWOT analysis of the typhoid Vi polysaccharide vaccine market.

For detailed insights on the key dynamics influencing the typhoid Vi polysaccharide vaccine market growth and SWOT analysis of the typhoid Vi polysaccharide vaccine industry, Read More

Typhoid Vi Polysaccharide Vaccine Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Typhoid Vi Polysaccharide Vaccine Market Report 2026

Name: Typhoid Vi Polysaccharide Vaccine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Child, Adult ), By Route Of Administration (Oral, Parenteral ), By Application (Government Institution, Private Sector, Other Applications ) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Typhoid Vi Polysaccharide Vaccine Market Overview

• Typhoid Vi Polysaccharide Vaccine market size has reached to $6.71 billion in 2025

• Expected to grow to $15.51 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%

• Growth Driver: Escalating Typhoid Prevalence Fuels Expansion In The Typhoid Vi Polysaccharide Vaccine Market

• Market Trend: Innovative Collaborations And Strategic Investments In Typhoid Vi Polysaccharide Vaccine Development

• Asia-Pacific was the largest region in 2025.

What Is Covered Under Typhoid Vi Polysaccharide Vaccine Market?

Typhoid VI polysaccharide vaccine refers to the recommendation of active immunization for people aged two and up, concerning the prevention of typhoid fever caused by Salmonella typhi.

The main types of typhoid VI polysaccharide vaccine are child and adult. A child is a person between birth and puberty, or full growth. The routes of administration for this vaccine include oral and parenteral and are applied in government institutions, the private sector, and others.

Typhoid Vi Polysaccharide Vaccine Market Global Report 2026 Market Report bar graph

What Is The Typhoid Vi Polysaccharide Vaccine Market Size and Share 2026?

The typhoid vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from $6.71 billion in 2025 to $7.92 billion in 2026 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to expansion of national immunization schedules, increased awareness of typhoid prevention, availability of polysaccharide vaccine formulations, growth of public vaccination campaigns, support from global health organizations.

What Is The Typhoid Vi Polysaccharide Vaccine Market Growth Forecast?

The typhoid vi polysaccharide vaccine market size is expected to see rapid growth in the next few years. It will grow to $15.51 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to increasing focus on mass immunization in endemic regions, rising investments in vaccine manufacturing capacity, expansion of adult vaccination programs, growing emphasis on travel-related immunization, increasing adoption of improved vaccine storage technologies. Major trends in the forecast period include increasing government-led immunization programs, rising demand for pediatric vaccination coverage, growing focus on preventive healthcare measures, expansion of public-private vaccine distribution models, enhanced emphasis on cold chain optimization.

Book your 30 minutes free consultation with our research experts

Global Typhoid Vi Polysaccharide Vaccine Market Segmentation

1) By Type: Child, Adult

2) By Route Of Administration: Oral, Parenteral

3) By Application: Government Institution, Private Sector, Other Applications

Subsegments:

1) By Child: Pediatric Formulations, Age-Specific Dosages

2) By Adult: Standard Adult Formulations, High-Risk Population Formulations

What Are The Drivers Of The Typhoid Vi Polysaccharide Vaccine Market?

Rising typhoid prevalence is expected to propel the growth of the typhoid Vi polysaccharide vaccine market going forward. Typhoid is an infection caused by the bacteria Salmonella Typhi that can be fatal and typically spreads through contaminated food or drink. The rise in typhoid prevalence is driven by poor sanitation, unsafe water sources, rapid urbanization, and increased exposure to contaminated food and water. The typhoid Vi polysaccharide vaccine market supports this rise by providing immunization for adults and children aged 2 years and older, offering protective immunity against Salmonella enterica serovar Typhi and reducing the burden of typhoid fever in endemic regions. For instance, in August 2024, according to data published by the UK Health Security Agency, laboratory-confirmed symptomatic enteric fever cases in England, Wales, and Northern Ireland increased with S. Typhi reaching 313 cases, S. Paratyphi A reaching 135 cases, and S. Paratyphi B reaching 18 cases. Therefore, the rising typhoid prevalence is driving the growth of the typhoid Vi polysaccharide vaccine industry.

The growing immunization campaigns are expected to propel the growth of the typhoid Vi polysaccharide vaccine market going forward. Immunization campaigns refer to delivery strategies used to quickly reach large numbers of individuals with one or more vaccines at national or sub-national levels. The rise in immunization campaigns is driven by increasing public-health focus on typhoid prevention in high-burden regions and the need to reduce antimicrobial resistance through widespread vaccination. Growing immunization campaigns support the Typhoid Vi polysaccharide vaccine by increasing vaccine awareness, accessibility, and coverage, ultimately reducing the incidence and transmission of typhoid fever. For instance, in June 2023, according to the UK Health Security Agency, a UK-based government agency, total of 3,502,566 children from Reception to Year 9 were vaccinated as part of the school-aged vaccination program in 2022–2023. Therefore, growing immunization campaigns are driving the growth of the typhoid Vi polysaccharide vaccine industry.

Key Players In The Global Typhoid Vi Polysaccharide Vaccine Market

Major companies operating in the typhoid vi polysaccharide vaccine market are Sanofi S.A., Merck & Co. Inc., PT Bio Farma, Bharat Biotech International Limited, Bio-Med Pvt. Ltd., Hualan Biological Engineering Inc., Indian Immunologicals Limited, Serum Institute of India Limited, Biological E Limited, Panacea Biotec Limited, Zydus Lifesciences Limited, Beijing Minhai Biotechnology Co. Ltd., Lanzhou Institute of Biological Products Co. Ltd., Chengdu Institute of Biological Products Co. Ltd., Wuhan Institute of Biological Products Co. Ltd., Eubiologics Co. Ltd., Incepta Vaccine Limited, GC Pharma, KM Biologics Inc., Bharat Immunologicals and Biologicals Corporation Limited, Sinovac Biotech Ltd., Bio Farma Indonesia

Global Typhoid Vi Polysaccharide Vaccine Market Trends and Insights

Major companies operating in the typhoid Vi polysaccharide vaccine market are focusing on strengthening their market position through strategic investments, such as funding partnerships for next-generation vaccine delivery platforms, to accelerate innovation and expand global immunization reach. Funding partnerships for next-generation vaccine delivery platforms refer to collaborative investment initiatives aimed at developing improved typhoid vaccination technologies particularly needle-free, thermostable, and easy-to-administer formats that enhance accessibility, coverage, and compliance in low-resource settings. For instance, in August 2023, SK Bioscience, a South Korea-based biotech company, together with Vaxxas, an Australia-based biotechnology company specializing in needle-free vaccine delivery, secured AUD 0.0054 billion (USD 0.00367 billion) in funding from Wellcome, a UK-based charitable foundation, to develop a typhoid conjugate vaccine delivered via a needle-free high-density microarray patch (HD-MAP). This innovation features a micro-projection patch that eliminates the need for traditional needles, thermostability that supports distribution in low-infrastructure regions, and the potential for simplified, pain-free administration, targeting improved global uptake of typhoid vaccination.

Need data on a specific region in this market?

Request Regional Data

Regional Outlook

Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Typhoid Vi Polysaccharide Vaccine Market?

The typhoid Vi polysaccharide vaccine market consists of sales of Vi capsular polysaccharide vaccine, and non-conjugated Vi polysaccharide vaccine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Typhoid Vi Polysaccharide Vaccine Market Report 2026?

The typhoid vi polysaccharide vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the typhoid vi polysaccharide vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Typhoid Vi Polysaccharide Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$7.92 billion
Revenue Forecast In 2035	$15.51 billion
Growth Rate	CAGR of 18.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Route Of Administration, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi S.A., Merck & Co. Inc., PT Bio Farma, Bharat Biotech International Limited, Bio-Med Pvt. Ltd., Hualan Biological Engineering Inc., Indian Immunologicals Limited, Serum Institute of India Limited, Biological E Limited, Panacea Biotec Limited, Zydus Lifesciences Limited, Beijing Minhai Biotechnology Co. Ltd., Lanzhou Institute of Biological Products Co. Ltd., Chengdu Institute of Biological Products Co. Ltd., Wuhan Institute of Biological Products Co. Ltd., Eubiologics Co. Ltd., Incepta Vaccine Limited, GC Pharma, KM Biologics Inc., Bharat Immunologicals and Biologicals Corporation Limited, Sinovac Biotech Ltd., Bio Farma Indonesia
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Typhoid Vi Polysaccharide Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Typhoid Vi Polysaccharide Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Typhoid Vi Polysaccharide Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Typhoid Vi Polysaccharide Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Government-Led Immunization Programs

4.2.2 Rising Demand For Pediatric Vaccination Coverage

4.2.3 Growing Focus On Preventive Healthcare Measures

4.2.4 Expansion Of Public-Private Vaccine Distribution Models

4.2.5 Enhanced Emphasis On Cold Chain Optimization

5. Typhoid Vi Polysaccharide Vaccine Market Analysis Of End Use Industries

5.1 Government Health Agencies

5.2 Public Hospitals

5.3 Private Hospitals

5.4 Immunization Centers

5.5 Travel Health Clinics

6. Typhoid Vi Polysaccharide Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Typhoid Vi Polysaccharide Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Typhoid Vi Polysaccharide Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Typhoid Vi Polysaccharide Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Typhoid Vi Polysaccharide Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Typhoid Vi Polysaccharide Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Typhoid Vi Polysaccharide Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Typhoid Vi Polysaccharide Vaccine Market Segmentation

9.1. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Child, Adult

9.2. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral

9.3. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Government Institution, Private Sector, Other Applications

9.4. Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Child, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric Formulations, Age-Specific Dosages

9.5. Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Adult, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Adult Formulations, High-Risk Population Formulations

10. Typhoid Vi Polysaccharide Vaccine Market Regional And Country Analysis

10.1. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market

11.1. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Typhoid Vi Polysaccharide Vaccine Market

12.1. China Typhoid Vi Polysaccharide Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Typhoid Vi Polysaccharide Vaccine Market

13.1. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Typhoid Vi Polysaccharide Vaccine Market

14.1. Japan Typhoid Vi Polysaccharide Vaccine Market Overview

14.2. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Typhoid Vi Polysaccharide Vaccine Market

15.1. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Typhoid Vi Polysaccharide Vaccine Market

16.1. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Typhoid Vi Polysaccharide Vaccine Market

17.1. South Korea Typhoid Vi Polysaccharide Vaccine Market Overview

17.2. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Typhoid Vi Polysaccharide Vaccine Market

18.1. Taiwan Typhoid Vi Polysaccharide Vaccine Market Overview

18.2. Taiwan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Typhoid Vi Polysaccharide Vaccine Market

19.1. South East Asia Typhoid Vi Polysaccharide Vaccine Market Overview

19.2. South East Asia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Typhoid Vi Polysaccharide Vaccine Market

20.1. Western Europe Typhoid Vi Polysaccharide Vaccine Market Overview

20.2. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Typhoid Vi Polysaccharide Vaccine Market

21.1. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Typhoid Vi Polysaccharide Vaccine Market

22.1. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Typhoid Vi Polysaccharide Vaccine Market

23.1. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Typhoid Vi Polysaccharide Vaccine Market

24.1. Italy Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Typhoid Vi Polysaccharide Vaccine Market

25.1. Spain Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market

26.1. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market Overview

26.2. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Typhoid Vi Polysaccharide Vaccine Market

27.1. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Typhoid Vi Polysaccharide Vaccine Market

28.1. North America Typhoid Vi Polysaccharide Vaccine Market Overview

28.2. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Typhoid Vi Polysaccharide Vaccine Market

29.1. USA Typhoid Vi Polysaccharide Vaccine Market Overview

29.2. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Typhoid Vi Polysaccharide Vaccine Market

30.1. Canada Typhoid Vi Polysaccharide Vaccine Market Overview

30.2. Canada Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Typhoid Vi Polysaccharide Vaccine Market

31.1. South America Typhoid Vi Polysaccharide Vaccine Market Overview

31.2. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Typhoid Vi Polysaccharide Vaccine Market

32.1. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Typhoid Vi Polysaccharide Vaccine Market

33.1. Middle East Typhoid Vi Polysaccharide Vaccine Market Overview

33.2. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Typhoid Vi Polysaccharide Vaccine Market

34.1. Africa Typhoid Vi Polysaccharide Vaccine Market Overview

34.2. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Typhoid Vi Polysaccharide Vaccine Market Regulatory and Investment Landscape

36. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape And Company Profiles

36.1. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Typhoid Vi Polysaccharide Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Typhoid Vi Polysaccharide Vaccine Market Company Profiles

36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. PT Bio Farma Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bharat Biotech International Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bio-Med Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Typhoid Vi Polysaccharide Vaccine Market Other Major And Innovative Companies

Hualan Biological Engineering Inc., Indian Immunologicals Limited, Serum Institute of India Limited, Biological E Limited, Panacea Biotec Limited, Zydus Lifesciences Limited, Beijing Minhai Biotechnology Co. Ltd., Lanzhou Institute of Biological Products Co. Ltd., Chengdu Institute of Biological Products Co. Ltd., Wuhan Institute of Biological Products Co. Ltd., Eubiologics Co. Ltd., Incepta Vaccine Limited, GC Pharma, KM Biologics Inc., Bharat Immunologicals and Biologicals Corporation Limited

38. Global Typhoid Vi Polysaccharide Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Typhoid Vi Polysaccharide Vaccine Market

40. Typhoid Vi Polysaccharide Vaccine Market High Potential Countries, Segments and Strategies

40.1 Typhoid Vi Polysaccharide Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Typhoid Vi Polysaccharide Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Typhoid Vi Polysaccharide Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Typhoid Vi Polysaccharide Vaccine Market, Overview Of Key Products - Product Examples

Table 2: Global Typhoid Vi Polysaccharide Vaccine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Typhoid Vi Polysaccharide Vaccine Market, Supply Chain Analysis

Table 4: Global Typhoid Vi Polysaccharide Vaccine Market, Major Raw Material Providers

Table 5: Global Typhoid Vi Polysaccharide Vaccine Market, Major Resource Providers

Table 6: Global Typhoid Vi Polysaccharide Vaccine Market, Major Manufacturers (Suppliers)

Table 7: Global Typhoid Vi Polysaccharide Vaccine Market, Major Distributors And Channel Partners

Table 8: Global Typhoid Vi Polysaccharide Vaccine Market, Key Technologies & Future Trends

Table 9: Global Typhoid Vi Polysaccharide Vaccine Market, Major Trends

Table 10: Global Typhoid Vi Polysaccharide Vaccine Market, Major End Users

Table 11: Global Typhoid Vi Polysaccharide Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Typhoid Vi Polysaccharide Vaccine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Typhoid Vi Polysaccharide Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Typhoid Vi Polysaccharide Vaccine Market - TAM, US$ Billion, 2025

Table 15: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Child, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Adult, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Typhoid Vi Polysaccharide Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Typhoid Vi Polysaccharide Vaccine Market - Company Scoring Matrix

Table 96: Sanofi S.A. Financial Performance

Table 97: Merck & Co. Inc. Financial Performance

Table 98: PT Bio Farma Financial Performance

Table 99: Bharat Biotech International Limited Financial Performance

Table 100: Bio-Med Pvt. Ltd. Financial Performance

Table 101: Global Typhoid Vi Polysaccharide Vaccine Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Typhoid Vi Polysaccharide Vaccine Market, Competitive Dashboard

Table 103: Global Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 105: Global, Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 106: Global, Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Typhoid Vi Polysaccharide Vaccine Market, Overview Of Key Products - Product Examples

Figure 2: Global Typhoid Vi Polysaccharide Vaccine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Typhoid Vi Polysaccharide Vaccine Market, Supply Chain Analysis

Figure 4: Global Typhoid Vi Polysaccharide Vaccine Market, Major Raw Material Providers

Figure 5: Global Typhoid Vi Polysaccharide Vaccine Market, Major Resource Providers

Figure 6: Global Typhoid Vi Polysaccharide Vaccine Market, Major Manufacturers (Suppliers)

Figure 7: Global Typhoid Vi Polysaccharide Vaccine Market, Major Distributors And Channel Partners

Figure 8: Global Typhoid Vi Polysaccharide Vaccine Market, Key Technologies & Future Trends

Figure 9: Global Typhoid Vi Polysaccharide Vaccine Market, Major Trends

Figure 10: Global Typhoid Vi Polysaccharide Vaccine Market, Major End Users

Figure 11: Global Typhoid Vi Polysaccharide Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Typhoid Vi Polysaccharide Vaccine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Typhoid Vi Polysaccharide Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Typhoid Vi Polysaccharide Vaccine Market - TAM, US$ Billion, 2025

Figure 15: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Child, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Adult, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Typhoid Vi Polysaccharide Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Typhoid Vi Polysaccharide Vaccine Market - Company Scoring Matrix

Figure 96: Sanofi S.A. Financial Performance

Figure 97: Merck & Co. Inc. Financial Performance

Figure 98: PT Bio Farma Financial Performance

Figure 99: Bharat Biotech International Limited Financial Performance

Figure 100: Bio-Med Pvt. Ltd. Financial Performance

Figure 101: Global Typhoid Vi Polysaccharide Vaccine Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Typhoid Vi Polysaccharide Vaccine Market, Competitive Dashboard

Figure 103: Global Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 105: Global, Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 106: Global, Typhoid Vi Polysaccharide Vaccine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Chickenpox Vaccine Market Report 2026 - Global Outlook – By Vaccine (Monovalent Varicella Vaccine, Combination Varicella Vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immuni...

Ruminant Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated Vaccines, Attenuated Or Modified Live Vaccines, Other Vaccine Types), By Indication (Bovine Respiratory Diseases (BRD), Diarrhea Or Sco...

Conjugate Vaccine Market Report 2026 - Global Outlook – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meni...

Typhoid Antibody Testing Market Report 2026 - Global Outlook – By Product Type (Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test), By Paratyphi Typ...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Typhoid Vi Polysaccharide Vaccine Market Report 2026 - Global Outlook – By Type (Child, Adult ), By Route Of Administration (Oral, Parenteral ), By Application (Government Institution, Private Sector, Other Applications ...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Frequently Asked Questions

How big is the Typhoid Vi Polysaccharide Vaccine Market?

The Typhoid Vi Polysaccharide Vaccine market was valued at $6.71 billion in 2025, increased to $7.92 billion in 2026, and is projected to reach $15.51 billion by 2030. request a sample here

What is the Typhoid Vi Polysaccharide Vaccine market growth?

The global Typhoid Vi Polysaccharide Vaccine market is expected to grow at a CAGR of 18.3% from 2026 to 2035 to reach $15.51 billion by 2035. request a sample here

Who are the key players in Typhoid Vi Polysaccharide Vaccine market?

Some Key Players in the Typhoid Vi Polysaccharide Vaccine market Include, Sanofi S.A., Merck & Co. Inc., PT Bio Farma, Bharat Biotech International Limited, Bio-Med Pvt. Ltd., Hualan Biological Engineering Inc., Indian Immunologicals Limited, Serum Institute of India Limited, Biological E Limited, Panacea Biotec Limited, Zydus Lifesciences Limited, Beijing Minhai Biotechnology Co. Ltd., Lanzhou Institute of Biological Products Co. Ltd., Chengdu Institute of Biological Products Co. Ltd., Wuhan Institute of Biological Products Co. Ltd., Eubiologics Co. Ltd., Incepta Vaccine Limited, GC Pharma, KM Biologics Inc., Bharat Immunologicals and Biologicals Corporation Limited, Sinovac Biotech Ltd., Bio Farma Indonesia . request a sample here

What is the anticipated growth trend for the Typhoid Vi Polysaccharide Vaccine market?

Major trend in this market includes: Innovative Collaborations And Strategic Investments In Typhoid Vi Polysaccharide Vaccine Development. For further insights on this market. request a sample here

Which region has the most growth potential in the Typhoid Vi Polysaccharide Vaccine market?

Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2025. The regions covered in the typhoid vi polysaccharide vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Typhoid Vi Polysaccharide Vaccine Market Report 2026 market?

Major companies operating in the Typhoid Vi Polysaccharide Vaccine Market Report 2026 market are Major companies operating in the typhoid vi polysaccharide vaccine market are Sanofi S.A., Merck & Co. Inc., PT Bio Farma, Bharat Biotech International Limited, Bio-Med Pvt. Ltd., Hualan Biological Engineering Inc., Indian Immunologicals Limited, Serum Institute of India Limited, Biological E Limited, Panacea Biotec Limited, Zydus Lifesciences Limited, Beijing Minhai Biotechnology Co. Ltd., Lanzhou Institute of Biological Products Co. Ltd., Chengdu Institute of Biological Products Co. Ltd., Wuhan Institute of Biological Products Co. Ltd., Eubiologics Co. Ltd., Incepta Vaccine Limited, GC Pharma, KM Biologics Inc., Bharat Immunologicals and Biologicals Corporation Limited, Sinovac Biotech Ltd., Bio Farma Indonesia request a sample here.

Which region has the most growth potential in the Typhoid Vi Polysaccharide Vaccine Market Report 2026 market?